ID: MRFR/HC/6651-HCR | February 2021 | Region: Global | 90 pages
The opioid withdrawal treatment market is expected to grow significantly over the forecast period. The market held a market value of USD 1.8 billion in 2020 and is projected to register a CAGR of 9.70% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain.
In some cases, usage of opioids causes addiction, and opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. The rising use of opioids for the management of pain, large healthcare expenditure, and rising chronic disorders is driving the growth of the market.
Recent FDA approval of first non-opioid treatment for the management of opioid withdrawal symptoms in adults is propelling the opioid withdrawal treatment market.
Additionally, the rising population affected with chronic disorders, along with favorable reimbursement scenarios, is driving the growth of the market. For instance, according to the United Nations, the older population is likely to reach 425 million by 2050. Additionally, according to the World Health Organization (WHO), in 201, more than 17.7 million people died from cardiovascular diseases contributing to 31% of all the global deaths. This rise in the aging population will lead to a rise in cardiovascular disorders as this population is highly prone to various heart disorders and is at a higher risk of developing complications which are also likely to drive the market.
However, the stringent regulatory scenario is limiting the growth of the market.
The opioid withdrawal treatment market has been segmented into drug type and distribution channel.
By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, analgesics, natural sleep supplements, and others.
On the basis of distribution channel, the market has been segmented into hospital pharmacy, retail pharmacies, and online stores.
The opioid withdrawal treatment market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The opioid withdrawal treatment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European opioid withdrawal treatment market has been segmented into Western Europe and Eastern Europe. Western Europe, opioid withdrawal treatment market, has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The opioid withdrawal treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Opioid withdrawal treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Opioid Withdrawal Treatment Market Share (%), by Region, 2018
Source: White Papers, Company Presentations, Annual Reports
The Americas is the market leader and has an attractive market for opioid withdrawal treatment owing to the increasing prevalence of chronic disorders and rising adoption of opioids for the management of pain. Additionally, the rising geriatric population is a major trigger factor that drives the opioid withdrawal treatment market. According to the Center for Disease Control and Prevention in2016, health care providers across the US wrote more than 214 million prescriptions for opioid pain medication, which is 66.5 prescriptions per 100 people.
Additionally, the CDC stated that drug overdoses claimed the lives of nearly 64,000 Americans in 2016. Nearly two-thirds of these deaths (66%) involved a prescription or illicit opioid. This overuse of opioids is driving the growth of the opioid withdrawal treatment market.
Moreover, according to the US Census Bureau, in 2016, around 49.2 million residents were aged 65 and above. This huge older population led to over 15.2% of the total population, which is likely to drive the market. Furthermore, the Americas is witnessing rampant advancements in technology, and increasing government initiatives, and funding for research in the drugs is driving the market growth.
Europe accounts for the second-largest market and holds a healthy share in the global opioid withdrawal treatment market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and rising opioid addiction. For instance, according to the European Monitoring Centre for Drugs and Drug Addiction, drug overdose deaths remain high in Europe, and opioids are implicated in the majority of cases. Moreover, according to the International Overdose Awareness Day, deaths due to the consumption of heroin and morphine doubled to 1,201 in 2015 in England and Wales. This is driving the growth of the market.
Asia-Pacific is expected to be the fastest-growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies. Moreover, due to lower cost of clinical trials, research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in opioid withdrawal treatment market in future.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.
Opioid Withdrawal Treatment Market, by Drug Type
Opioid Withdrawal Treatment Market, by Distribution Channel
Opioid Withdrawal Treatment Market, by Region
|Market Size||2030: Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Drug Type, Distribution Channel|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Merck & Co., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis, Sanofi, Johnson & Johnson Services, F. Hoffmann-La Roche Ltd, and Bayer AG|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The opioid withdrawal treatment market has the scope to record a CAGR of 9.70% during the forecast period of 2020 to 2030.
The opioid withdrawal treatment market volume in 2018 was of USD 1.8 billion.
The opioid withdrawal treatment market is getting backed by first time FDA approval of the non-opioid treatment.
Hospital pharmacies, retail pharmacies, and online stores are the major end users of the opioid withdrawal treatment market.
Different types reported for a discussion of the opioid withdrawal treatment market are anti-nausea medications, nonsteroidal anti-inflammatory drugs, natural sleep supplements, analgesics, and others.